Acurx Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Acurx Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2021 to Q3 2024.
  • Acurx Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -392 %, a 75.6% decline year-over-year.
  • Acurx Pharmaceuticals, Inc. annual Return On Equity for 2023 was -290 %, a 119% decline from 2022.
  • Acurx Pharmaceuticals, Inc. annual Return On Equity for 2022 was -132 %, a 16% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -392 -169 -75.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -371 -187 -102% Apr 1, 2024 Jun 30, 2024
Q1 2024 -308 -150 -95.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -290 -157 -119% Oct 1, 2023 Dec 31, 2023
Q3 2023 -223 -113 -103% Jul 1, 2023 Sep 30, 2023
Q2 2023 -184 -75.1 -69% Apr 1, 2023 Jun 30, 2023
Q1 2023 -158 -52.7 -50% Jan 1, 2023 Mar 31, 2023
Q4 2022 -132 -18.2 -16% Oct 1, 2022 Dec 31, 2022
Q3 2022 -110 +18.2 +14.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -109 Apr 1, 2022 Jun 30, 2022
Q1 2022 -105 Jan 1, 2022 Mar 31, 2022
Q4 2021 -114 Oct 1, 2021 Dec 31, 2021
Q3 2021 -128 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.